Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer

Explore a 32-minute webinar presented by Dr. Branden Moriarity, a Tenured Associate Professor specializing in Hematology/Oncology. Delve into the development of Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer. Learn about the limitations of current CAR-NK cell therapies using viral vectors and discover how non-viral transposon engineering paired with CRISPR/Cas9 editing addresses these challenges. Gain insights into innovative approaches for tackling difficult solid tumor types. Understand the potential of this cutting-edge immunotherapy technique in treating advanced ovarian cancer. Earn PACE credits by watching the webinar and following the provided instructions. Connect with Labroots on various social media platforms for more scientific content and updates.

Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer